This study aims to evaluate the effects of a combined "cocktail", cessation intervention of brief advice, nicotine replacement therapy sampling and active referral (BANSAR) for smoking expectant fathers on smoking cessation outcomes
Secondhand smoke (SHS) exposure cause substantial harms to pregnant women, foeti and infants. Smoking cessation (SC) interventions for smoking expectant fathers are needed particularly in China where male smoking predominates and many pregnant women (about 30% in Hong Kong) were exposed to SHS. Prenatal period presents a valuable teachable moment to engage smoking expectant father in tobacco dependence treatment. However, most smoking cessation trials were conducted in the Western countries on smoking pregnant women or smoking couples. Very few trials were designed to target fathers quitting. Given the busy clinical settings in Hong Kong Public Hospitals, evidence-based, low-cost and sustainable brief cessation intervention applicable in real-world practice is imperative. Informed by previous research, a combined cessation intervention of brief advice, nicotine replacement therapy sampling and active referral (BANSAR) has been developed for smoking expectant father. This multicentre, pragmatic, assessor-blinded, individually-randomized controlled trial aims to evaluate BANSAR for smoking cessation outcomes in smoking expectant father visiting prenatal clinics in Hong Kong
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
1,053
Subject will receive brief, face-to-face counselling following a structured AWARD model at baseline : 1. Ask: smokers will be asked about their smoking behaviour 2. Warn about the harms of smoking using a leaflet which contain information about harms of secondhand smoke to women, fetus and infant, motivational messages to quit and smoking cessation services. 3. Advise to quit or reduce their smoking and use the provided 1-week nicotine replace therapy sample as soon as possible 4. Refer smokers to smoking cessation services if they agree. 5. Do-it-again: repeat the AWARD advise through telephone boosters at 2-week and 4-week after baseline
Subjects will receive 1-week supply of free nicotine patch or gum with dosage based on participants' number of cigarette per day. An information card containing reminders of nicotine replacement therapy use and actions to handle potential side effects will be provided.
School of Nursing, The University of Hong Kong
Hong Kong, Hong Kong
Biochemically-validated abstinence
Defined by an exhaled carbon monoxide level of \< 4 parts per million (ppm)
Time frame: 6-month after baseline
Self-reported past 7-day abstinence
Being completely smoke-free in the past 7 days
Time frame: 3-month after baseline
Self-reported past 7-day abstinence
Being completely smoke-free in the past 7 days
Time frame: 6-month after baseline
Self-reported continuous abstinence in the past 24-week
Being completely smoke-free in the past 24-week
Time frame: 6-month after baseline
Smoking reduction
Defined by at least 50% reduction in baseline daily number of cigarettes
Time frame: 3-month after baseline
Smoking reduction
Defined by at least 50% reduction in baseline daily number of cigarettes
Time frame: 6-month after baseline
Smoking cessation service use
Any access to a smoking cessation service
Time frame: 3-month after baseline
Smoking cessation service use
Any access to a smoking cessation service
Time frame: 6-month after baseline
Use of nicotine replacement therapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Subjects will be encouraged to select and access a smoking cessation services in Hong Kong. If the subjects agree, their contact information will be sent to the smoking cessation service providers for further arrangement.
Subjects will receive general advice to quit
Subjects will receive a standard leaflet on perinatal smoking by Department of Health
Any use of nicotine replacement therapy
Time frame: 3-month after baseline
Use of nicotine replacement therapy
Any use of nicotine replacement therapy
Time frame: 6-month after baseline
Change in nicotine dependence
Assessed by Heaviness of Smoking Index (range 0 to 6 with higher score indicating greater nicotine dependence)
Time frame: 3-month after baseline
Change in nicotine dependence
Assessed by Heaviness of Smoking Index (range 0 to 6 with higher score indicating greater nicotine dependence)
Time frame: 6-month after baseline
Number of quit attempt
Defined by abstinence for at least 24 hours
Time frame: 3-month after baseline
Number of quit attempt
Defined by abstinence for at least 24 hours
Time frame: 6-month after baseline
Intention to quit
Defined by readiness to quit in 30 days
Time frame: 3-month after baseline
Intention to quit
Defined by readiness to quit in 30 days
Time frame: 6-month after baseline